To assess quality of life and cost-effectiveness of additional acupuncture treatment for allergic rhinitis, patients were randomly allocated to 2 groups; both received usual care, but one group received an additional 10 acupuncture sessions. Quality of life (according to the SF-36 Health Survey), and direct and indirect costs, were assessed at baseline and after 3 months, and the incremental cost-effectiveness ratio of acupuncture treatment was calculated. This German study (December 2000-June 2004) involved 981 patients (64% women, mean age 40.9 years (standard deviation, 11.2); 36% men, mean age 43.2 years (standard deviation, 13.0)). At 3 months, quality of life was higher in the acupuncture group than in the control group (mean Physical Component Score 51.99 (standard error (SE), 0.33) vs. 48.25 (SE, 0.33), P < 0.001; mean Mental Component Score 48.55 (SE, 0.42) vs. 45.35 (SE, 0.42), respectively, P < 0.001). Overall costs in the acupuncture group were significantly higher than those in the control group (Euro (e; e1 ¼ US $1.27)763, 95% confidence interval: 683, 844 vs. e332, 95% confidence interval: 252, 412; mean difference e432, 95% confidence interval: 318, 545). The incremental cost-effectiveness ratio was e17,377 per quality-adjusted life year (women, e10,155; men, e44,871) and was robust in sensitivity analyses. Acupuncture, supplementary to routine care, was beneficial and, according to international benchmarks, costeffective. However, because of the study design, it remains unclear whether the effects are acupuncture specific.
Allergic rhinitis has become a major health problem. In the past 2 decades, there has been a marked increase in the prevalence of allergic rhinitis (1) . Direct yearly costs for allergic rhinitis in Europe are estimated at Euro (e; e1 ¼ US $1.27)1.0-1.5 billion, whereas indirect costs are estimated at e1.0-2.0 billion (1) . Two categories of costs are associated with allergic rhinitis: direct costs for treatment and indirect costs including lost productivity for medical reasons. A study in the United States showed that 55% of employees suffered from allergic rhinitis, with an average duration of 55 days per year (2) . Because of allergic rhinitis, they were absent from work an average of 3.6 days per year and were unproductive 2.3 hours per day because of the symptoms. Assuming that patients with allergic rhinitis use their medication (e.g., intranasal glucosteroids, topical antihistamine) for up to 6 months per year, the annual costs may range between e400 and e500 per patient (3) .
A remarkable number of patients are turning to complementary and alternative medicine, such as acupuncture, for relief. The lifetime prevalence of use of complementary and alternative medicine by patients with allergic rhinitis ranges from 27% to 46%, and most patients who have not yet used it intend to do so in the future (4, 5) . In particular, acupuncture is used by 17%-19% of allergic rhinitis patients (4, 5) . A recent study from Australia showed that acupuncture was more effective than a sham acupuncture treatment for persistent allergic rhinitis (6) .
In Germany, acupuncture is mainly administered by physicians. It is a relatively resource-intensive intervention because of the time involved for physicians and patients alike (7) . To date, there is a lack of information on costs and the cost-benefit relation of acupuncture treatment in patients with allergic rhinitis.
Therefore, the objective of the present study was to investigate quality of life, costs, and cost-effectiveness of acupuncture in addition to routine care, compared with routine care alone, among patients with allergic rhinitis. This study is part of the Acupuncture in Routine Care (ARC) studies, a large research initiative on acupuncture started and funded by the German statutory health insurance companies.
MATERIALS AND METHODS

Study design
In a multicenter, randomized controlled trial, patients (!18 years of age) with a clinical diagnosis of seasonal and/or perennial allergic rhinitis and symptoms that required treatment were enrolled after initial presentation to a physician participating in this study. Exclusion criteria were all forms of nonallergic rhinitis. The patients were randomly allocated to an acupuncture group that received immediate acupuncture treatment or to a control group that received delayed acupuncture treatment after 3 months. We used a central telephone randomization procedure and a random list generated with SAS software (SAS Institute, Inc., Cary, North Carolina). Both groups were free to use conventional routine medical care supported by the German statutory health insurance companies. All study participants provided written, informed consent, and the study protocol was approved by the appropriate ethics review boards. Participating physicians were required to have received at least 140 hours of acupuncture training. The acupuncture treatments consisted of 10-15 sessions. The study period, including follow-up and availability of economic data, was December 2000-June 2004. The outcomes for allergic rhinitis-specific quality of life, measured with the Rhinitis Quality of Life Questionnaire, are published elsewhere (8) .
This paper focuses on the cost-effectiveness part of the study. As an effectiveness parameter, general quality of life was measured by using the Self-Rated Health Survey (SF-36) questionnaire (9) , which assessed quality of life over the last 7 days, at baseline, and after 3 months.
Costs considered were those for direct health care, such as for acupuncture, physicians' visits, and hospital stays (without consideration of private individual billing), as well as prescription medication (including patients' copayments). The payment for each acupuncture session was e35. The cost perspective of the study was societal. Therefore, in addition to health insurance costs, we also assessed indirect costs caused by patients' incapacity to work. These indirect costs were determined by using the human capital approach (10) and were estimated to be e78 per sick day off from work. All cost data were provided by the statutory health insurance companies.
We calculated 1) the overall costs during the study period of 3 months after randomization, including costs not related to allergic rhinitis; and 2) diagnosis-specific costs by using codes from the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, to identify costs due to allergic rhinitis and related conditions only.
Economic analyses
When higher costs and a better medical outcome was found, incremental cost-effectiveness analyses were performed. The SF-36 values were transformed into healthstatus utilities by using an algorithm developed by Brazier et al. (11) . Only those patients for whom SF-36 data were complete could be included in the cost-effectiveness analysis. Quality-adjusted life years (QALYs) gained were calculated by adopting the area-under-the-curve method (12, 13) , using the following formula:
Our analysis was based on the utility values at each time point (a ¼ baseline utility, b ¼ utility after 3 months) and used the common assumption of a linear change over time (12) . After the intervention period of 3 months, we assumed a linear decrease in the effects of acupuncture, returning to a baseline level 12 months after the start of the study.
Because the baseline values for the SF-36 and the healthstatus utilities could differ for subgroups in both treatment groups (particularly for male patients, where the sample size was smaller), we adjusted QALYs gained for this baseline difference. For these purposes, we added the difference in the health-status utilities between both groups at baseline to QALYs gained, as follows:
We calculated the incremental cost-effectiveness ratio (ICER) by using the following relation (14) :
The net-benefit approach (15) was used to measure the incremental cost-effectiveness against a societal threshold value k, often described as society's willingness to pay for 1 extra QALY gained. Bootstrapped cost-effectiveness results were transformed into net-benefit values given varying threshold values and were then plotted in a cost-effectiveness acceptability curve. Under a Bayesian framework, the cost-effectiveness acceptability curve shows the probability that, for a whole range of values for k, the incremental costeffectiveness is below k (16). For a given value for k, an intervention would be considered cost-effective if its net benefit is greater than zero or, in other words, the ICER lies below k. Thus, a new treatment should replace the existing one when the net benefit under k is greater than zero (16) .
In the United Kingdom, the National Institute for Clinical Excellence found a threshold of £30,000 per QALY to be consistent with decisions to adopt new technologies (17) . In Germany, such a threshold does not yet exist, so an arbitrary and hypothetical threshold of a maximum of e50,000 per QALY was used.
Sensitivity analyses
In our additional sensitivity analyses, we considered a variety of acupuncture cost scenarios (e15-e55 per acupuncture session) and different durations of therapeutic and economic effects (up to 5 years). As part of our calculations, we assumed that the differences in quality-of-life outcome observed between the 2 treatment groups would gradually decrease over time. For sensitivity analyses, the study situation was defined as base case. In an economic model calculation, we took into account the possibility that a variation in one specific parameter could result in modified therapeutic effect differences between the groups. Thus, we considered variations in a physician's payment alone, as well as the possibility that a decreased (or increased) physician's fee might result in reduced (or improved) clinical effectiveness. Regarding acupuncture treatment, the impact of unspecific factors on treatment results has been widely discussed in the literature (18). For example, lower fees for acupuncture sessions may reduce the intensity of the physician-patient relationship, patient expectations, or treatment satisfaction. Furthermore, some evidence suggests that different payment systems have different impacts on clinical outcomes (19, 20) . Therefore, we assumed that a reduction in the cost of an acupuncture session from e35 (base case) to e15 would be associated with a 50% reduction in QALY differences, whereas an increase to e55 would result in a 50% increase in QALY differences.
For the base-case scenario, there was no need to discount any costs or effects because the observation period was less than 1 year. In the sensitivity analyses, we discounted the measured future QALY effects at 1.5% and costs at 3% per year. The discount rates are compatible with those published previously (21, 22) .
Statistical analyses
Student's t test and Fisher's exact test were used to compare sociodemographic baseline characteristics. For the quality-of-life data, we used analysis of covariance and adjusted for baseline values. Furthermore, an analysis of covariance was applied with age and gender as covariates to estimate costs and cost differences between the groups 3 months before and after study onset.
To derive cost-effectiveness acceptability curves, we used nonparametric bootstrapping. The original sample was bootstrapped 1,000 times to obtain 1,000 means for cost and effect differences and the resulting ICERs. These bootstrap results were used to build the cost-effectiveness acceptability curves, as described above.
For inferential statistics, we used SPSS version 11.0 software (SPSS Inc., Chicago, Illinois). Microsoft Office Excel 2003 software (Microsoft Corporation, Redmond, Washington) was used to model cost-effectiveness analyses for patient subgroups and to perform the additional sensitivity analyses. The significance level was a ¼ 5%.
RESULTS
Baseline characteristics
A total of 981 randomized patients (487 acupuncture, 494 control) with allergic rhinitis were enrolled between December 2000 and August 2001 for this cost analysis. For all patients, sociodemographic and economic data were available (Table 1) . At baseline, there were no significant differences between the 2 treatment groups, except for the use of cortisone, which was higher in the acupuncture group (P ¼ 0.009). Complete quality-of-life data (SF-36), which was the basis for the QALY calculation, were available for 825 (84%) patients (418 acupuncture, 407 control). These patients were included in the cost-effectiveness analysis.
Cost analysis
The patients in the acupuncture group received on average a mean of 10.5 (standard deviation, 2.8) acupuncture sessions during the 3-month study. The mean overall cost per acupuncture patient during the study period was e763. Table 2 ). In the overall cost analysis, we observed higher indirect costs in the acupuncture group (P ¼ 0.03). However, this finding was not evident in the diagnosisspecific analyses.
Overall and diagnosis-specific costs were higher in the acupuncture group compared with the control group ( Table 2) . The mean cost difference between both treatment groups 3 months after study entry (total overall: e431.51, 95% CI: 317.77, 545.25; diagnosis specific: e364.92, 95% CI: 347.60, 382.24) was essentially due to the actual acupuncture costs in the acupuncture group (e366.98, 95% CI: 361.01, 372.94).
When we analyzed costs excluding acupuncture, we found no significant difference in overall cost between the 2 study groups (P ¼ 0.28).
Quality of life
Quality-of-life data to calculate the SF-36 component scores were available for 901 patients at baseline and for 844 patients after the 3-month study duration. At baseline, we found no significant differences for the whole study population and the female subgroup, with the exception of the subscale role-physical (Table 3) . However, in the male subgroup, we found at baseline a significant difference for all subscales, showing better quality of life in the control group. At 3 months, patients in the acupuncture group had a significantly better quality of life according to all SF-36 dimensions (Table 3 ). This finding was mainly for the female subgroup, whereas we found nearly no significant group differences for the male subgroup (Table 3) 
Cost-effectiveness analysis
More QALYs were gained in the acupuncture group compared with the control group. However, this difference was associated with additional costs (Table 4 ). The unadjusted ICER was 22,798 (overall) and e18,470 (diagnosis specific) per QALY gained (Table 4 ). The probability that this intervention is cost-effective was approaching 100% for the threshold value of e50,000 (Figure 1 ). After adjustment for QALY-utility differences at baseline, the overall ICER was e17,377 and the diagnosis-specific ICER was e14,079 per QALY gained (Table 4) .
Substantial differences were observed in the analysis of gender-specific cost-effectiveness. In the female study population, acupuncture was more cost-effective (the overall unadjusted ICER was e7,720 and the diagnosis-specific adjusted ICER was e10,155 per QALY gained). On the contrary, in the male subgroup, acupuncture patients gained Analysis of the Cost-Effectiveness of Acupuncture 565 fewer QALYs than controls did (difference between groups: mean À0.023 QALYs (standard error, 0.112)), which resulted in a negative ICER. After adjustment for QALY baseline differences, there was a QALY difference in favor of the acupuncture group (0.015 (standard error, 0.006))-the adjusted ICER was e44,871 per QALY gained-and the probability of reaching the cost-effectiveness level was approximately 60% according to an international threshold value of e50,000 (Figure 2 ).
Sensitivity analysis
Changing the parameter ''physician payment rate'' by itself (i.e., without considering any effect this change might have on treatment effects) led to major changes in the costeffectiveness of acupuncture (Table 5 ). When the acupuncture fee was reduced to e15 per session, the overall ICER was e9,329, whereas a higher fee of e55 led to an ICER of e25,208 per additional QALY. Similarly, changing the parameter ''effect duration'' by itself had a marked influence on the cost-effectiveness of acupuncture treatment. The overall ICER ranged from e17,337 in the base case to e7,389 in the hypothetical scenario of an effect within a 5-year period.
Subsequently, we investigated whether a decrease in the effectiveness of acupuncture treatment due to a reduction in the physician payment rate (or, conversely, an improvement in the effectiveness of acupuncture treatment due to an increase in the payment rate) might affect the cost-effectiveness of acupuncture treatment. However, our calculations showed that neither scenario would lead to major changes in the cost-effectiveness of acupuncture treatment, which confirms the robustness of our findings. Discounting the monetary costs and benefits by up to 10% as well as varying the discount rates for effects between 0% and 5% did not change the major findings of our study.
DISCUSSION
For patients with allergic rhinitis, acupuncture in addition to routine care compared with routine care alone was associated with a better quality of life as well as higher costs. This cost increase was essentially due to the acupuncture costs themselves and was not compensated for by savings associated with other health-care components during the study period. The overall ICER, adjusted for baseline values, was e17,377 per QALY and proved robust in additional sensitivity analyses. When we adopted a threshold of e50,000 per QALY gained, acupuncture, in addition to routine care, was therefore relatively cost-effective. We observed relevant gender differences. Acupuncture was more cost-effective for women than for men (ICER e10,155 vs. e44,871).
The strengths of our study are that it was performed in a setting that reflects the situation of usual care in Germany; it used a large sample size that allowed for robust estimation of costs, a validated and internationally accepted qualityof-life questionnaire, and a modern state-of-the-art costeffectiveness analysis including the first known calculation of ICERs for acupuncture treatment in patients with allergic rhinitis; and, to our knowledge, it incorporated the first calculation of ICERs for patients with allergic rhinitis based on QALYs. Use of the Brazier algorithm to calculate QALYs tends to generate relatively higher ICERs compared with other approaches (23) . Therefore, our analysis is based on a conservative approach.
This pragmatic study cannot answer whether the effects observed may be due, at least in part, to the ''placebo'' effect. A further limitation of our study design is that the treatment group received acupuncture as a form of add-on treatment, whereas the control group received routine care alone. As a result, there was no control for the add-on acupuncture group; therefore, our positive findings must be interpreted with caution. A recent study found a significant difference between acupuncture and sham acupuncture (6), but 2 recently published reviews on the efficacy of acupuncture in allergic rhinitis yielded inconsistent results (24, 25) .
In addition, our study design and methodology did not enable us to distinguish between patients with seasonal allergic rhinitis and those with perennial allergic rhinitis. However, because of the randomization procedure, an equal distribution of both types of allergic rhinitis could be assumed. It seems unlikely that type of allergic rhinitis relevantly influenced the overall effect size of treatment.
Another limitation arises from the duration of the study. The cost and effectiveness data were compared between the 2 groups for 3 months after baseline since patients in the waiting-list control group were also subsequently offered acupuncture after 3 months. Therefore, we could not investigate possible long-term health economic effects. In addition, patients were not blinded, which could have affected treatment outcome. Because we aimed to perform a cost-effectiveness analysis on the basis of QALYs (i.e., a cost-utility analysis), it was not possible to use a more disease-specific quality-of-life questionnaire (e.g., Rhinitis Quality of Life Questionnaire). The advantage of cost-utility analyses is that quality of life as an outcome parameter includes both treatment benefits and side effects. A further limitation might be the fact that the only sources of costs were the companies' statutory health insurance databases.
Therefore, private expenses, such as over-the-counter medication, could not be included.
Because the statutory health insurance databases were used, all patient contacts within the German health care system were captured apart from the purely ''private'' ones paid for exclusively by the patients. Patients insured by one of the approximately 300 statutory health insurance companies in Germany (87.8% of the population) (26) have free choice of physicians, and their visits are (almost without exception) covered by the statutory health insurance company. Thus, costs for private visits to physicians were considered negligible.
Since, during the present study, acupuncture was not routinely reimbursed by the statutory health insurance companies in Germany, costs of the acupuncture session were determined arbitrarily. Additional sensitivity analyses were performed according to varying assumptions, including modeling of the effect duration of 1-5 years and the projection of different acupuncture session costs of e15-e55. One might argue, however, that a reduction in physicians' payment could perhaps result in lower treatment effects, leading to a less favorable ICER and a decreased probability of cost-effectiveness.
We found noticeable and relevant gender differences. Acupuncture was shown to be beneficial for women, whereas we found no benefit for men. That acupuncture in usual care is more beneficial for female patients than for male patients was also found in another study from our group of patients with chronic neck pain (27) . It is well known that more female than male patients seek complementary medicine (28) . However, this difference does not explain why they have better treatment outcomes. Other studies by our group showed a higher expectation of a better treatment outcome in acupuncture patients suffering from pain (29) . In the present study, the patients were not blinded, and expectation could have influenced the outcome. It might be possible that women have higher expectations than men do. This possibility was not assessed in our study but should be taken into account in further studies. In the current study, the cost differences between the acupuncture and the control groups were twice as high for male patients than for female patients, indicating that men had used more conventional treatments. However, in the male subgroup, there were quality-of-life baseline differences between the acupuncture group and the control group, indicating a lower quality of life in the acupuncture group, which could have caused higher resource use in the acupuncture group. Nevertheless, in our analysis, we adjusted the ICER for the quality-utility differences at baseline, and even though the ICER for the male subgroup was not as negative after adjustment, the large difference in costeffectiveness between men and women remained. For further studies on acupuncture, it could be helpful to stratify randomization for gender.
In conclusion, our study showed that using acupuncture in addition to routine care to treat patients with allergic rhinitis resulted in a benefit and was, according to international benchmarks, cost-effective. Acupuncture was more costeffective for women than for men. However, because of the study design, it remains unclear whether the effects are acupuncture specific.
